Cervomed to participate in the emerging growth conference 66

Boston, jan. 05, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced that company's management will provide a corporate update at the emerging growth conference 66, to be held virtually from january 10-11, 2024.

CRVO Ratings Summary

CRVO Quant Ranking